Apps Purchases: 10+ Million Software Purchases
Founded in 2010, APPS RUN THE WORLD is a leading technology intelligence and market-research company devoted to the application space. Leveraging a rigorous data-centric research methodology, we ask the simple B2B sales intelligence question: Who’s buying enterprise applications from whom and why?
Our global team of 50 researchers has been studying the digital transformation initiatives being undertaken by 2 million + companies including technographic segmentation of 10 million ERP, EPM, CRM, HCM, Procurement, SCM, Treasury software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Apps Run The World Buyer Insight and Technographics Customer Database has over 100 data fields that detail company usage of emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database, and different on-prem and cloud apps by function, customer size (employees, revenues), industry, country, implementation status, year deal won, partner involvement, Line of Business Key Stakeholders and key decision-makers contact details, including the systems being used by Fortune 1000 and Global 2000 companies.
Apply Filters For 10+ Million Software Purchases
- ERP Financial Management
- ERP Services and Operations
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | VAR/SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | SAP | SAP S/4 HANA | ERP Financial | 2023 | n/a | ||
|
|
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | Emerson Automation Solutions | Emerson Asset Management | Asset Performance Management | 2015 | n/a | In 2015, GSK deployed Emerson Asset Management as an Asset Performance Management solution to standardize calibration and asset stewardship workflows. The deployment focused on instrument calibration, digital recordkeeping, and workflow orchestration for maintenance and quality functions. Emerson Asset Management was positioned to create a single source of truth for asset status and calibration history. Configuration emphasized calibration management capabilities, an asset registry, scheduling and work order orchestration, and controlled documentation to replace paper-based processes, consistent with Asset Performance Management functionality. Workflow automation and approval routing were configured to support end-to-end calibration lifecycle events, from scheduling through verification and closeout. The implementation used Emerson Asset Management's core modules to enforce data integrity and auditability for regulated processes. The program specifically targeted calibration operations and instrument management, where GSK reported process-level outcomes. GlaxoSmithKline reported eliminating 21,000 sheets of paper per year, and streamlined its end-to-end workflow, which reduced calibration time by about 15 minutes per calibration. Those outcomes indicate digital form capture and automated record linking were incorporated into day-to-day maintenance operations. Governance changes included standardized procedures, digital signoffs, and centralized calibration records to support compliance and traceability across maintenance and quality teams. Rollout required updating standard operating procedures and targeted training to operationalize the Emerson Asset Management workflows. | |
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | Hexagon | HxGN EAM (Ex. Infor EAM) | Enterprise Asset Management | 2016 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | Hexagon | Hexagon Infor CMMS | Computerized Maintenance Management (CMMS) | 2016 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | Accruent | Accruent EMS | Facility Management | 2015 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | SAP | SAP S/4 HANA Credit Management (FIN-FSCM-CR) | Credit Union Management | 2015 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | Clario | Clario eCOA Clinical Trials | Clinical Trial Management | 2024 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | STARLIMS | STARLIMS | Laboratory Management | 2021 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | LabWare | LabWare LIMS | Laboratory Management | 2021 | n/a |
|
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | AspenTech | Aspen Unscrambler | Asset Performance Management | 2023 | n/a |
|
|